297 related articles for article (PubMed ID: 11504835)
21. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
22. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
23. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors.
Pitz S; Moll R; Störkel S; Thoenes W
Lab Invest; 1987 Jun; 56(6):642-53. PubMed ID: 2439772
[TBL] [Abstract][Full Text] [Related]
24. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas.
Wu SL; Kothari P; Wheeler TM; Reese T; Connelly JH
Mod Pathol; 2002 Jul; 15(7):712-7. PubMed ID: 12118108
[TBL] [Abstract][Full Text] [Related]
25. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
[TBL] [Abstract][Full Text] [Related]
26. Alpha-methyl CoA racemase expression in renal cell carcinomas.
Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
[TBL] [Abstract][Full Text] [Related]
27. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
[TBL] [Abstract][Full Text] [Related]
28. CD10 is expressed in a subset of chromophobe renal cell carcinomas.
Martignoni G; Pea M; Brunelli M; Chilosi M; Zamó A; Bertaso M; Cossu-Rocca P; Eble JN; Mikuz G; Puppa G; Badoual C; Ficarra V; Novella G; Bonetti F
Mod Pathol; 2004 Dec; 17(12):1455-63. PubMed ID: 15286660
[TBL] [Abstract][Full Text] [Related]
29. [Carcinoma and oncocytoma of the kidney. Phenotypic characteristics and prognostic features].
Störkel S
Veroff Pathol; 1993; 140():1-165. PubMed ID: 8434485
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
31. Pax-2 expression in adult renal tumors.
Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
[TBL] [Abstract][Full Text] [Related]
32. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
[TBL] [Abstract][Full Text] [Related]
33. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
Gobbo S; Eble JN; Delahunt B; Grignon DJ; Samaratunga H; Martignoni G; Zhang S; Wang M; Brunelli M; Cossu-Rocca P; Cheng L
Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.
Gonzalez-Roibon N; Faraj SF; Munari E; Bezerra SM; Albadine R; Sharma R; Argani P; Allaf ME; Netto GJ
Hum Pathol; 2014 Feb; 45(2):244-8. PubMed ID: 24315206
[TBL] [Abstract][Full Text] [Related]
35. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
36. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
[TBL] [Abstract][Full Text] [Related]
37. [Adult renal neoplasms in the material of the Pathology Department of the Szeged University].
Németh I; Sükösd F; Béli L; Kiss A; Pajor L; Mikó T; Iványi B
Orv Hetil; 2005 Apr; 146(14):653-8. PubMed ID: 15889540
[TBL] [Abstract][Full Text] [Related]
38. Malignant effusion of chromophobe renal-cell carcinoma: cytological and immunohistochemical findings.
Teresa P; Grazia ZM; Doriana M; Irene P; Michele S
Diagn Cytopathol; 2012 Jan; 40(1):56-61. PubMed ID: 22180239
[TBL] [Abstract][Full Text] [Related]
39. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
[TBL] [Abstract][Full Text] [Related]
40. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
Garcia E; Li M
Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
